|
|
|
|
LEADER |
02765nam a2200325 u 4500 |
001 |
EB002072219 |
003 |
EBX01000000000000001212309 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
220923 r ||| eng |
100 |
1 |
|
|a Anderson, Johanna
|
245 |
0 |
0 |
|a Evidence brief: Use of intradialytic parenteral nutrition (IDPN) to treat malnutrition in hemodialysis patients
|h Elektronische Ressource
|c prepared for Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research And Development Service ; prepared by Evidence-Based Synthesis Program (ESP) Coordinating Center, Portland VA Medical Center ; investigators, Johanna Anderson, Kim Peterson, Donald Bourne, Erin Boundy
|
246 |
3 |
1 |
|a IDPN for malnutrition in hemodialysis
|
246 |
3 |
1 |
|a Use of intradialytic parenteral nutrition (IDPN) to treat malnutrition in hemodialysis patients
|
260 |
|
|
|a Washington, DC
|b Department of Veterans Affairs, Health Services Research And Development Service
|c 2018, March 2018
|
300 |
|
|
|a 1 PDF file (i, 27 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
700 |
1 |
|
|a Peterson, Kim
|e [author]
|
700 |
1 |
|
|a Bourne, Donald
|e [author]
|
700 |
1 |
|
|a Boundy, Erin
|e [author]
|
710 |
2 |
|
|a United States
|b Department of Veterans Affairs
|
710 |
2 |
|
|a Portland VA Medical Center
|b Evidence-based Synthesis Program Center
|
710 |
2 |
|
|a Quality Enhancement Research Initiative (U.S.)
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Evidence-based synthesis program
|
500 |
|
|
|a At head of title: QUERI.
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK518608
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a Chronic kidney disease (CKD) is a major public health concern, affecting 14.8% of US adults in 2011-2014, and was the 9th leading cause of death in the US in 2016. Progression of CKD leads to end-stage renal disease (ESRD), a total and permanent failure of kidney function requiring kidney transplant or maintenance hemodialysis. More than half (63.1%) of all prevalent ESRD cases receive hemodialysis, and despite its advantages, hemodialysis patients often suffer poor health outcomes, including substantially worse survival rates than the general population. The most recent systematic review from 2010 concluded that data at that time were insufficient to definitively determine the benefit of IDPN.47 However, since 2010, 3 new randomized controlled trials have emerged. The objective of this evidence brief is to synthesize the evidence regarding the effectiveness, harms, and cost-effectiveness of using intradialytic parenteral nutrition (IDPN) in hemodialysis patients with malnutrition
|